SWOT Analysis for Boston Scientific Corp.

Expensive Stars (DVM)
Consistent Highest Return Stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Increasing profits every quarter for the past four quarters
Near 52 Week High
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Increasing Revenue every Quarter for the past 4 Quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Increasing profits every quarter for the past 4 quarters
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding
Negative Breakdown Third Support (LTP < S3)
PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Top Losers
Negative Breakdown First Support (LTP < S1)
Negative Breakdown Second Support (LTP < S2)
Negative Breakdown third support (LTP < S3)
Declining Net Cash Flow : Companies not able to generate net cash
Top Losers